Cleared Traditional

K162199 - Cascade IOMAX Intraoperative Monitor

K162199 is an FDA 510(k) clearance for Cascade IOMAX Intraoperative Monitor, manufactured by Cadwell Industries, Inc.. The device is a Class 2 Neurology device with product code GWF cleared through the Traditional 510(k) pathway after a 209-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2017
Decision
209d
Days
Class 2
Risk

K162199 is an FDA 510(k) clearance for the Cascade IOMAX Intraoperative Monitor. Classified as Stimulator, Electrical, Evoked Response (product code GWF), Class II - Special Controls.

Submitted by Cadwell Industries, Inc. (Kennewick, US). The FDA issued a Cleared decision on March 2, 2017 after a review of 209 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1870 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Cadwell Industries, Inc. devices

FDA 510(k) Submission Details - K162199

510(k) Number K162199 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 05, 2016
Decision Date March 02, 2017
Days to Decision 209 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
60d slower than avg
Panel avg: 149d · This submission: 209d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWF Device Classification - Class 2, Special Controls

Product Code GWF Stimulator, Electrical, Evoked Response
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1870
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWF Stimulator, Electrical, Evoked Response

All 107
Devices cleared under the same product code (GWF) and FDA review panel - the closest regulatory comparables to K162199.
The EPAD 2 System
K182542 · Safeop Surgical, Inc. · Feb 2019
Neurovision Nerve Locator Monitor (Nerveana), EMGView Software
K170677 · Neurovision Medical Product, Inc. · Apr 2017
MEP Monitor
K162873 · Tonica Elektronik A/S · Mar 2017
MagPro R20
K160280 · Tonica Elektronik A/S · May 2016
STM 9000 Basic, STM 9000 Standard, STM 9000 Fast, STM 9000 Ultra-Fast
K150220 · Eb Neuro S.P.A. · Aug 2015
Neuromaster G1 MEE200
K142624 · Nihon Kohden Corporation · Apr 2015